REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...
A phase 1 trial of a peripheral artery disease drug candidate from TheraVasc demonstrated safety in diabetic patients. The positive clinical trial data reported by Cleveland-based TheraVasc ...
DETROIT -- The DMC Cardiovascular Institute announced Wednesday that it will participate in Connect II, a global clinical trial conditionally approved by the FDA that gives physicians access to Ocelot ...
HAIFA, Israel, Apr 27, 2010 (GlobeNewswire via COMTEX) -- Pluristem Therapeutics Inc. /quotes/comstock/15*!psti/quotes/nls/psti (PSTI 1.34, +0.02, +1.52%) (DAX:PJT ...
Healthcare developer Philips has announced the commencement of a US clinical trial for a new treatment of peripheral artery disease (PAD). Characterized by a narrowing of the arteries supplying blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results